NIH-funded research Career grant

Investigating the causes of bleeding in the brain related to amyloid buildup

Official title: Causes and Consequences of Leptomeningeal Bleeding in Cerebral Amyloid Angiopathy

Funded at Massachusetts General Hospital · NIH-10991800 · Data updated 2026-11-12

This study is looking at how a buildup of a protein in the brain's blood vessels can cause bleeding and other problems, especially in older adults, to help find better ways to prevent these issues for people with this condition.

More Bleeding research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startDecember 1, 2023
Project endNovember 30, 2028
Funding year2025
Award (this year)$230,071
NIH project number5K08NS131530-02
Project IDNIH-10991800 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are elderly individuals diagnosed with cerebral amyloid angiopathy who are at risk for intracerebral hemorrhage.

Less likely to help

Patients without cerebral amyloid angiopathy or those who are not elderly may not benefit from this research.

What this research studies

This research focuses on understanding cerebral amyloid angiopathy (CAA), a condition where amyloid-β protein accumulates in the blood vessels of the brain, leading to bleeding and other complications, particularly in older adults. The study aims to explore how severe CAA and associated leptomeningeal bleeding contribute to brain hemorrhages. Using advanced imaging techniques and mouse models, researchers will examine the mechanisms behind these bleeding events and their effects on brain health. The goal is to uncover new insights that could lead to better prevention strategies for brain hemorrhages in patients with CAA.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for brain hemorrhages in elderly patients with cerebral amyloid angiopathy.

How similar studies have gone: While the specific focus on leptomeningeal bleeding in CAA is novel, related research has shown promising results in understanding amyloid-related brain conditions.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Kozberg, Mariel Gailey — Massachusetts General Hospital
  • Study coordinator: Kozberg, Mariel Gailey

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.